Clinical trial
Study of the SafeSeal(TM) Hemostasis Patch Following Percutaneous Coronary…
NCT00481741 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00481741 |
|---|---|
| Title | Study of the SafeSeal(TM) Hemostasis Patch Following Percutaneous Coronary Artery and Peripheral Vascular Interventions |
| Official title | A Prospective Randomized Controlled Efficacy and Safety Trial of the SafeSeal Hemostasis Patch Compared to Manual Compression for Achieving Vascular Hemostasis Following Percutaneous Coronary and Peripheral Intervention. |
| Lead sponsor | University of Rochester, Other |
| Collaborators | MEDRAD, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Peripheral Vascular Disease |
| Intervention type | Device |
| Interventions | SafeSeal(TM) Hemostasis Patch |
| Enrollment | 150 |
| Start date | May 1, 2007 |
| Primary completion | Oct 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 4, 2007 |
| Last update posted | Jul 31, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: